SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Elite football players 'more likely to develop dementia'
Fri March 17th - Elite male footballers are more likely to develop dementia than the general population, according to a Swedish study published today. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OUR CLIENTS
THIS WEEK'S STORIES
Pharmaceuticals

Pharmaceuticals

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68

16/03/2023 - Malfunctioning immune cell linked to long COVID
The malfunctioning behaviour of an immune cell could be linked to specific symptoms of long COVID, opening the way to treatments, British researchers have reported. More

15/03/2023 - Common cough medicines withdrawn
The opioid pholcodine, a common component of cough and cold medicines, is to be removed from the British market, it was announced yesterday. More

09/03/2023 - New bone cancer drug unveiled
A new drug could treat the main types of primary bone cancer without toxic side effects, British researchers say. More

08/03/2023 - New drug for obese could cut stones
NHS specialist weight loss services are to have access to a drug which can reduce body weight by about 12%, it was announced today. More

03/03/2023 - Peptide to treat MND
A peptide given as a nasal spray might treat motor neurone disease, British scientists have suggested. More

02/03/2023 - Move opioid patients to alternative therapies - guidance
A drive to reduce opioid prescriptions in primary care is having success as patients move to therapeutic alternatives to drugs, it was announced today. More

01/03/2023 - Vaccine may improve long COVID symptoms
Vaccination may reduce the severity and impact of long COVID symptoms, researchers report today. More

21/02/2023 - Three COVID treatments gain approval
Regulators today endorse three medicines for treating adults with COVID-19 as part of a clinical and cost-effectiveness review. More

17/02/2023 - Breakthrough made in next generation cancer treatment
A new generation of light-activated cancer treatments has become a step closer to reality, UK researchers have revealed. More

16/02/2023 - COVID protection drug rejected
A drug designed to protect vulnerable patients against COVID is unlikely to be effective enough, according to UK regulators. More

14/02/2023 - 'Catastrophic' rise in antibiotic resistance in Iraq
Decades of wars and conflict in Iraq have led to a “catastrophic” rise in antibiotic resistance in the country, international experts warn today. More

02/02/2023 - Most antidepressants 'ineffective' for pain relief
Most antidepressants are ineffective for pain relief – or evidence to support their use is inconclusive, according to new analysis published last night. More

01/02/2023 - New indication for cannabis treatments
The NHS is to support a new use of cannabis-derived medicines, it has been announced. More

01/02/2023 - Concern over switching Parkinson's drugs
Patients with Parkinson’s disease should be protected against unplanned switching of the brand of drugs they take, campaigners have warned. More

20/01/2023 - Chemotherapy first approach reduces risk of colon cancer return
Chemotherapy before surgery reduces the risk of colon cancer returning in two years by 28%, according to a new study. More

13/01/2023 - NICE calls for more people to be offered statins
More people in England could be offered statins, following newly published draft guidance from NICE. More

12/01/2023 - Cough medicine treatment for Parkinson's disease trial
A £5.5 million phase III trial is to begin in the UK this year, studying whether a cough medicine can help to slow down the progression of Parkinson’s disease. More

23/12/2022 - England to get somatrogon for growth hormone deficiency
Children being treated for growth disturbance could be treated with injections weekly instead of daily, according to new guidance. More

20/12/2022 - Newborns not at higher risk of being colonised by hospital pathogens
Healthy newborn babies are not at higher risk than adults of being colonised by antimicrobial-resistant gut bacteria in hospital, a new study has found. More

20/12/2022 - Nasal COVID antibodies short-lived
The next generation of COVID vaccines should include nasal sprays because other vaccines have limited impact on protective levels in the nose, British researchers have suggested. More

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68

Printer friendly page Printer friendly page

CATEGORIES